At Walton Hospital Diabetes Centre, Liverpool, during the period 2002–2003, approximately 500 people with type 2 diabetes were started on insulin therapy as outpatients. Traditionally, these people have been assessed for insulin therapy by a diabetes specialist nurse (DSN) then referred onto the diabetes nurse educators (DNEs) to continue the plan of education and support. An education checklist was used as a guide for the nursing team to follow and to aid the standardisation of care, which can provide an optimal level of diabetes care with consistency for all people with the condition. The aim was to complete insulin initiation and education over a 3-month period. The nursing team at Walton consists of a nurse consultant, four DSNs and three DNEs. The role of the DNE evolved from the pressure on specialist nurse time to cope with the number of people starting on insulin. The following standards were included in the education checklist and agreed by the nursing team for people initiated onto insulin.
- Injection technique is to be reassessed within 1 week.
- Blood glucose monitoring technique is to be reassessed within 1 week.
- If dietary issues resulted in poor glycaemic control then those patients were reassessed for insulin initiation, then seen for a dietary review. Others who are initiated onto insulin are to be referred to a dietitian and seen within, due to pressures on the dietetic department, 6 weeks.
- Patients are to be offered five appointments over 3 months.
- HbA1c and weight are to be recorded pre- and 3 months post-insulin therapy.
- Patients are to be discharged from nurse-led insulin clinic at 3 months.
In 2004 a retrospective audit was undertaken to compare documented care against the agreed standards.
Aims of the audit
The aims of the retrospective audit were as follows.
- To establish whether people with diabetes were offered an equitable nursing service when starting insulin therapy, therefore adhering to the audit standards.
- To determine the average duration of nursing time spent, on all aspects of care, from assessment to discharge.
- To review the educational aspects (such as advice on hypoglycaemia, driving and sick day rules; Table 1) covered during the process.
- To assess the current standard of documentation.
Methods
The case notes of 20 people with type 2 diabetes, who had been started on insulin therapy as an outpatient, were retrospectively audited. Data were collected for the following: age, sex, duration of diabetes, pre- and post-insulin initiation levels of HbA1c, and pre- and post-insulin initiation body mass index (BMI), the frequency of contacts between the care team and the person with diabetes, review of practical skills, referral to dietitian and duration of care (Table 2).
Results of first audit
Mean age was 60 years (range 38–80), mean duration of diabetes was 7.5 years (range 1.5–18), 11 patients were female. Following insulin initiation, seven (35%) people had injection technique reassessed and only five (25%) had monitoring technique reassessed (as per audit standard; these techniques were initially assessed at the first DSN visit). Fourteen (70%) people were referred to the dietitian but only 10 (50%) were seen within 6 weeks of referral. The mean number of visits to the DSN was three (range 1–6). Average duration of care was 4 months. Mean BMI before insulin initiation was 31.7kg/m2 and 32.9kg/m2 following insulin initiation. Mean HbA1c before insulin initiation was 9.9% and which fell to 8.2% after insulin initiation (Table 2).
Conclusion of first audit
The quality of care, compared with the standards, was variable: only 13 (65%) people were reviewed at the clinic after 1 month of insulin initiation and reassessment of the practical aspects of self-monitoring of blood glucose levels and self-injecting fell short of our expectations. Thirteen (65%) people did not have a review of injection technique and 15 (75%) did not have blood glucose monitoring skills reassessed. This was a cause of great concern as titration of insulin doses by DSNs relies on the individual’s skills of measuring and recording blood glucose levels and self-injecting.
Documentation of education provided was recorded by the completion of a checklist. This made it difficult to determine the content of education provided or whether individual needs were addressed. The checklist merely served as a prompt for topics to be discussed, which allowed differences in interpretation of what details should be covered and in what depth. It was also not clear from the documentation why some people were seen more frequently than others by the nursing team. There was also a concern that a dietitian had seen only 10 (50%) people following insulin initiation. This is well below the standard.
The anabolic effect of insulin in people with type 2 diabetes can result in weight gain (Makimattila et al, 1999). It is therefore generally accepted that people with type 2 diabetes should be offered support and dietary review. However, from the nursing documentation it was not clear how many people had actually been referred to the dietetic service.
Production of the care pathway
As a result of this audit it was decided to introduce a care pathway for people with type 2 diabetes starting on insulin therapy. Care pathways have been used successfully in other areas of nursing, such as continence care, and have been reported to improve the standard and consistency of care (Bayliss and Salter, 2004). Care pathways have been developed and shown to be effective in delivering high standards of evidence-based care, such as the individual’s experience of outpatient clinics and education programmes (O’Brien and Hardy, 2003). The aim of the pathway was to define a minimal standard of care for all individuals starting on insulin therapy and to include elements of self-care, as described by the National Service Framework for diabetes (Department of Health, 2001). National Institute for Health and Clinical Excellence guidelines (2003) advocate the use of patient education models for diabetes – recommending that all people with diabetes should be offered structured education, including individuals starting on insulin.
The pathway consisted of a series of five appointments over a 3-month period. The first appointment was with a DSN for an initial assessment, followed by three appointments with a DNE for education on titration of doses as well as other on other topics, and then a final appointment with the DSN for a review and discharge after 3 months (Table 1).
The pathway encouraged a structured assessment of each person by the specialist nurse, including physical and social factors, which may impact on the individual’s ability to safely administer insulin. The format also involved a series of clinic visits to focus on education, support and evaluation of the individual’s needs.
A problem-solving approach utilising scenarios was included in the pathway to provide practical examples (of, for example, hypoglycaemia and foot care) for discussion. It also incorporated a section for specific questions and indicated the support literature to be given and explained at each visit. At the end of a 3-month period individuals were reviewed by the DSN and discharged from the nurse-led clinic if appropriate. The care pathway was piloted for 6 months then a further audit was completed.
Results of second audit
The use of the care pathway improved the overall standard of documentation of nurse and patient contacts. All individuals had been offered an equal number of appointments within their 3-month period. Telephone contact was still variable, however, this was patient-driven as each person on the care pathway had agreed that telephone contact would be initiated by the patients themselves. Of 20 individuals, 16 were discharged from the care pathway after 3 months. The remaining four were reviewed in poor-control clinics because their HbA1c levels did not improve enough after 3 months – defined as HbA1c reduction of less than 1% and remaining over 8%, calculated by laboratory assays aligned to the Diabetes Control and Complications Trial, therefore allowing comparison between centres.
Focusing on the standards that were set, only one person (5%) did not have injection technique reviewed and only two people (10%) did not have blood glucose monitoring skills reassessed. Referral rate to the dietetic service increased; however, 13 individuals (65%) did not have a dietary review within 6 weeks of referral (Table 2) This was associated with a lack of resources in the department at that time, and some of the dietitians covering the service were not familiar with the care pathway so had documented in clinical notes instead. Glycaemic control improved with insulin therapy in those who were audited prior to the implementation of the care pathway and those after.
Feedback from the nurses using the pathway
Structured education split over five visits was a more comprehensive method of delivering education. Any nurse in the team would be able to follow the pathway and know how the individual is coping with insulin therapy. As a result of using the care pathway nurses were able to have more contacts with the patients, cover more educational topics and scenarios, and assess the individual’s quality of life. Therefore the pathway made the consultations more time efficient. The inclusion of educational scenarios helped individuals express their understanding of particular aspects of advice given throughout the 3-month period. The nursing team enjoy using the pathways.
Conclusion
The use of a care pathway helps to achieve a minimum standard of care for people with type 2 diabetes starting on insulin therapy by individual’s needs being assessed on a continual basis at each visit. There is flexibility within the pathway to address the individual’s needs. Although the nursing time did not differ with either type of education model, the feedback from the team reinforced that the pathway was more efficient use of nursing time. The nursing documentation using the pathway was clear, concise and in chronological order, all in line with Nursing and Midwifery Council (NMC) standards of accurate record keeping (NMC, 2005). Both audits confirmed that insulin therapy improved glycaemic control in the people studied. The successful results illustrated by the audit of the care pathway has encouraged the development of other care pathways to be used at Walton Diabetes Centre.
Su Down looks back on a year of change and achievement.
17 Dec 2024